… Alzheimer's Disease (AD) is one of the leading causes of … to gain considerable attention in
AD detection research, with the … to be more accurate for AD detection compared to general …

… Alzheimer's disease (AD) is the leading cause of dementia in the elderly, affecting more
than 35 million people worldwide [1]. Aging populations in developed countries ensure that AD …

… ’s early manifestation and instruction for early detection and treatment. Identifying early
MCI (… for the early detection of Alzheimer’s disease. A method for early AD detection using …

In a 1981 pupillometric study, we found a supersensitive miotic response to ocular administration
of the muscarinic agonist pilo-carpine (0.125%) in patients with Alzhei-mer's dementia …

… As our ability to detect brain changes related to AD improves, so does our ability to detect
patients at increased risk for AD by using neuroimaging. Neuroimaging techniques offer the …

… the promise, possibly in the near future, of disease-modifying therapies have made the
characterization of the early stages of Alzheimer's disease (AD) a topic of major research interest. …

While APOE ɛ4 is the major genetic risk factor for Alzheimer’s disease (AD), amyloid
dysmetabolism is an initial or early event predicting clinical disease and is an important focus for …

The recent failures of potential disease-modifying drugs for Alzheimer's disease (AD) may
reflect the fact that the enrolled participants in clinical trials are already too advanced to derive …

… brain changes related to Alzheimer's disease in the research setting are PET-based amyloid
markers, which detect molecular pathology specific to Alzheimer's disease, and markers of …

… data for early diagnosis of Alzheimer's disease (AD) and its … a far better result for AD detection
than the methods using … 4D fMRI data is significant for AD detection and can increase the …